Comparative Pharmacology

Head-to-head clinical analysis: DELFLEX W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DELFLEX W DEXTROSE 2 5 LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER.

Peer-Reviewed Evidence

Differential Analysis

DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER vs DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER

Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.

DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

Peritoneal dialysis solution

Category C

DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER

Peritoneal dialysis solution

Category C

Head-to-Head

Clinical Matrix

Mechanism of Action

Delflex with Dextrose 2.5% is a peritoneal dialysis solution that provides osmotic ultrafiltration and electrolyte replacement. Dextrose creates an osmotic gradient across the peritoneal membrane, promoting fluid removal. The solution corrects electrolyte imbalances and removes metabolic waste products via diffusion and convection.

Peritoneal dialysis solution; dextrose provides osmotic gradient for ultrafiltration and solute removal; low magnesium and low calcium concentrations maintain electrolyte balance.

Clinical Dosing

Intraperitoneal administration: 2-3 L per exchange, 4 exchanges per day, with dwell times of 4-6 hours; typical total volume 8-12 L daily.

Intraperitoneal: 2.5% dextrose solution with low magnesium (0.25 mEq/L) and low calcium (2.5 mEq/L); typical exchange volume 2-2.5 L per exchange, 4-5 exchanges per day for continuous ambulatory peritoneal dialysis.

Direct Interaction

None Documented